Table 1.
Sr | Molecular Test | Anti-body Test | Antigen Test | |||
---|---|---|---|---|---|---|
RT-PCR | RT-LAMP | ELISA | IgG/IgM Lateral Flow Assay | |||
1 | What it detects: | Viral RNA | Viral RNA | Antibody | Antibody | Viral Antigens (Specific proteins on the surface of virus) |
2 | Sample taken from: | Nasopharyngeal Swab, sputum, saliva, stool | Same as RT-PCR | Blood | Human serum, plasma, or whole blood | Nasal or throat swab |
3 | Performed in: | Lab | Lab or Point-of-care | Lab | Point-of-care | Lab |
4 | Time Required: | 3–4 h | Variable (35 min–3 h) | 1–3 h | 10–20 min | 15 min |
5 | Specificity: | High | High | High (after at least 14 days of active infection) | High (after at least 14 days of active infection) | Moderate |
6 | Sensitivity: | High | High | High (after at least 14 days of active infection) | High (after at least 14 days of active infection) | Moderate |
7 | What it tells | Active coronavirus infection | Active coronavirus infection | Past coronavirus infection | Past coronavirus infection | Active coronavirus infection |
8 | Pros: | Commonly used; gold standard |
Rapid Results can be detected by naked eye |
Simple and cheap |
Simple; cheap; fast; visual inspection possible |
Positive results are usually highly accurate |
9 | Cons: |
Requires bulky, expensive, and specialized equipment to analyze the results The time needed to complete the test is high; trained personnel is required |
The design of primers can be complex; more chances of primer-to-primer interaction Qualitative test (challenging to quantify the results, i.e., the level of viral infection) |
Not well established; it can take from days to several weeks to develop antibodies enough to be detected |
Does not show active coronavirus infection Needs a PCR validation |
A higher chance of missing an active infection (less sensitive than molecular tests); negative results may need to be confirmed via a molecular test |
10 | Cost | High | Moderate | Low | Low | Low |